These days, the invasion of privacy is making headlines all the time and the public wants more transparency from the government and those organizations that we have interest in. We want to know what information the government is collecting on us when we make a phone call, send an email or text message, “tweet”, update Facebook or surf the web, and subsequently, what that data is being used for. We want to know the salaries of our favorite athletes, celebrities and prominent CEO’s, and the endorsement deals they may be involved in. This concept of transparency is now becoming a reality in the eClinical world as well with the full implementation of the Sunshine Act.
Beginning this month (August 2013), the Sunshine Act, which is part of the Affordable Care Act, will be a reality for all pharmaceutical and medical device companies. This provision will require that these companies report any financial interactions that they have with physicians or other health care providers (HCP) who are prescribing their products. Any payments, gifts, or transfers of value over $10 from drug and medical device manufacturers to HCP’s must be disclosed to the public. The reports will be sent to the Centers for Medicare and Medicaid Services (CMS) on an annual basis, and the data will then be presented to the public.